Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    8622034 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay
Conditions: Sarcoma;   Rectal Carcinoma;   Esophagus Cancer
Intervention: Radiation: Standard treatment
2 Withdrawn Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Condition: Soft Tissue Sarcomas
Interventions: Drug: Chemoradiotherapy Temozolomide;   Radiation: Proton therapy;   Procedure: Proton Chemoradiotherapy followed by surgery

Indicates status has not been verified in more than two years